Guido Oelkers
Guido Oelkers
Chief Executive Officer

Born 1965. Employed since 2017. 

Education: PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London, Complementary studies in Economics, London School of Economics and Political Science.

Other assignments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT, Member of the Board of Directors at Sartorius AG.

Previous positionsCEO BSN Medical, President & CEO Gambro, EVP Commercial Operations Nycomed, CEO Invida, Global Head of Healthcare DKSH, previous managerial roles at Aventis and preceding entities, member of the Board of Directors at Meda.

Shareholding in the company: 49,000

Henrik Stenqvist
Henrik Stenqvist
Chief Financial Officer

Born 1967. Employed since 2018.

Education: Degree in Finance and Business Administration from the University of Linköping, Sweden.

Other assignments: Board member of Midsona AB.        

Previous positions:  CFO Recipharm, CFO Meda, CFO Pharmalink, Regional Finance Director Astra Zeneca, Finance Director Astra Export & Trading, Financial Manager, Astra Hungary.

Shareholding in the company: 28,000

Torbjörn Hallberg
Torbjörn Hallberg
General Counsel and Head of Legal Affairs

Born 1969. Employed since 2018. 

Education: Master of Laws from the University of Lund, Sweden.

Previous positions: Vice President, General Counsel, Emerging Markets at Takeda Pharmaceuticals. Senior Director and Senior Corporate Counsel, Takeda Pharmaceuticals, Corporate Counsel, Nycomed Pharma, Corporate Counsel, Ferring Pharmaceuticals, Senior Associate/Lawyer at Advokatfirman Lindahl.

Shareholding in the company: 8,500

Sofiane Fahmy
Sofiane Fahmy
Head of Southern and Western Europe & North Africa

Born 1972. Employed since 2013.

Education: Degree in Marketing, University of Paris XI France, Degree in Pharmacy University of Poitiers, France

Previous positionsGeneral Manager Sobi France and North AfricaManagerial roles at Pfizer, Commercial roles at GSK, Brand Manager Hospital Products Roche.

Shareholding in the company: 0

Anne-Marie de Jonge
Anne Marie de Jonge Schuermans
Head of Technical Operations

Born: 1972. Employed since 2018.

Education: PhD from Swiss Federal Institute of Technology Zurich (ETHZ); M.Sc. degrees in Agriculture & Natural Environment from Wageningen Agricultural University in the Netherlands and in Environmental Management & Technology from the Ecole Polytechnique Féderale Lausanne (EPFL) in Switzerland.

Previous positions: Biogen, Vice President for Global Supply Chain Operations & Strategic Partnerships, and Executive Board Member of Biogen International GmbH; more than 15 years of experience in the healthcare industry from Biogen, Stryker and Novartis.

Shareholding in the company: 0

Norbert Oppitz
Norbert Oppitz
Head of Specialty Care

Born 1967. Employed since 2017.

Education: Dipl. BW (FH)/Business Administrator, FH Rhenania Palatina/Mainz, Germany

Previous positions: Member of the Executive Committee of BSN Medical in charge of Latin America. Member of the Executive Committee of Endo Pharmaceuticals, Emerging Markets. Head of Latin America, Takeda/Nycomed as well as country management roles at Roche Pharmaceuticals and Aventis Pharma.

Shareholdings in the company: 12,000

Amy Pott
Amy Pott
Head of North America

Born: 1976. Employed since 2019.

Education: Master of Science, European Policy & Intl Relations, London School of Economics & BA (Hons), History, University of Bristol.

Previous positions: Group Vice President, US Franchise Head Internal Medicine & Oncology as well as Head of Commericial Operations at Shire. Vice President, Global Market Access, & Vice President, Strategy, Planning & Analytics at Baxalta, Several Managerial roles at Baxter Healthcare.

Shareholding in the company: 0

Armin Reininger
Armin Reininger
Head of Medical and Scientific Affairs

Born 1957. Employed since 2017. 

Education: MD, PhD, Ludwig-Maximilians University Munich, Germany; certified specialist in Transfusion Medicine.

Previous positions: Head of Medical Affairs EMEA Hemophilia, Baxter. Head of Global Medical Affairs Hematology, Baxalta. Head of Medical Affairs EMEA Hematology Baxalta/Shire. Senior Physician University Clinic Munich. Harvard Medical School & Mass. General Hospital, Boston, MA. The Scripps Research Institute, La Jolla, CA. Professor of Anatomy at the Ludwig Maximilians-University Munich, Germany.

Shareholding in the company: 0

Paula Treutiger
Paula Treutiger
Head of Communications & Investor Relations

Born 1967. Employed since 2019. 

Education: Degree in Finance and Business Administration, Stockholm University.

Previous positions:  Director Corporate Communications & Investor Relations Medicover, Corporate Communications, IR and Sustainability Meda, Portfolio Manager Swedbank, VP Corporate Communications Gambro, Financial Analyst Carnegie and Alfred Berg.

Shareholding in the company: 2,500

Philip Wood
Philip Wood
Head of Haemophilia

Born 1968. Employed since 2012

Education: BSc Joint Honours degree in Geology and Physical Geography, Charted Institute of Marketing certification, UK.

Previous appointments: Head of European Strategic Asset team, Haemophilia, and Business Unit Head Haemophilia, UK, Pfizer

Shareholding in the company: 29,014

 

Milan Zdravkovic
Milan Zdravkovic
Head of Research & Development, Chief Medical Officer

Born 1970. Employed since 2016.

Education: MD, PhD University of Aarhus, Denmark, MSc Pharmaceutical Medicine, University of Surrey, United Kingdom

Other assignments: Board member of Selma Diagnostics Aps

Previous positions: Corporate Vice President, Novo Nordisk.18 years in the R&D organisation at Novo Nordisk responsible for diabetes, devices, growth hormone deficiency, obesity and immunology.

Shareholding in the company: 8,820